# Ozone Plasma on Lung Function and Inflammatory Parameters in Pulmonary Sequelae Associated With Coronavirus 19 Infection

> **NCT05089305** · PHASE2 · UNKNOWN · sponsor: **Centro Universitario de Ciencias de la Salud, Mexico** · enrollment: 35 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Ozone plasma

## Key facts

- **NCT ID:** NCT05089305
- **Lead sponsor:** Centro Universitario de Ciencias de la Salud, Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-04
- **Primary completion:** 2022-11-25
- **Final completion:** 2022-12-21
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2021-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05089305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05089305, "Ozone Plasma on Lung Function and Inflammatory Parameters in Pulmonary Sequelae Associated With Coronavirus 19 Infection". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05089305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*